Neuromedin U type 1 receptor stimulation of A-type K+ current requires the βγ subunits of Go protein, protein kinase A, and extracellular signal-regulated kinase 1/2 (ERK1/2) in sensory neurons
- PMID: 22493291
- PMCID: PMC3365707
- DOI: 10.1074/jbc.M111.322271
Neuromedin U type 1 receptor stimulation of A-type K+ current requires the βγ subunits of Go protein, protein kinase A, and extracellular signal-regulated kinase 1/2 (ERK1/2) in sensory neurons
Abstract
Although neuromedin U (NMU) has been implicated in analgesia, the detailed mechanisms still remain unclear. In this study, we identify a novel functional role of NMU type 1 receptor (NMUR1) in regulating the transient outward K(+) currents (I(A)) in small dorsal root ganglion (DRG) neurons. We found that NMU reversibly increased I(A) in a dose-dependent manner, instead the sustained delayed rectifier K(+) current (I(DR)) was not affected. This NMU-induced I(A) increase was pertussis toxin-sensitive and was totally reversed by NMUR1 knockdown. Intracellular application of GDPβS (guanosine 5'-O-(2-thiodiphosphate)), QEHA peptide, or a selective antibody raised against the Gα(o) or Gβ blocked the stimulatory effects of NMU. Pretreatment of the cells with the protein kinase A (PKA) inhibitor or ERK inhibitor abolished the NMU-induced I(A) response, whereas inhibition of phosphatidylinositol 3-kinase or PKC had no such effects. Exposure of DRG neurons to NMU markedly induced the phosphorylation of ERK (p-ERK), whereas p-JNK or p-p38 was not affected. Moreover, the NMU-induced p-ERK increase was attenuated by PKA inhibition and activation of PKA by foskolin would mimic the NMU-induced I(A) increase. Functionally, we observed a significant decrease of the firing rate of neuronal action potential induced by NMU and pretreatment of DRG neurons with 4-AP could abolish this effect. In summary, these results suggested that NMU increases I(A) via activation of NMUR1 that couples sequentially to the downstream activities of Gβγ of the G(o) protein, PKA, and ERK, which could contribute to its physiological functions including neuronal hypoexcitability in DRG neurons.
Figures







Similar articles
-
Neuromedin U inhibits T-type Ca2+ channel currents and decreases membrane excitability in small dorsal root ganglia neurons in mice.Cell Calcium. 2011 Jan;49(1):12-22. doi: 10.1016/j.ceca.2010.11.002. Epub 2010 Nov 23. Cell Calcium. 2011. PMID: 21106238
-
Activation of neuromedin U type 1 receptor inhibits L-type Ca2+ channel currents via phosphatidylinositol 3-kinase-dependent protein kinase C epsilon pathway in mouse hippocampal neurons.Cell Signal. 2010 Nov;22(11):1660-8. doi: 10.1016/j.cellsig.2010.06.006. Epub 2010 Jul 1. Cell Signal. 2010. PMID: 20599609
-
Serotonin type-1D receptor stimulation of A-type K(+) channel decreases membrane excitability through the protein kinase A- and B-Raf-dependent p38 MAPK pathways in mouse trigeminal ganglion neurons.Cell Signal. 2016 Aug;28(8):979-88. doi: 10.1016/j.cellsig.2016.05.004. Epub 2016 May 6. Cell Signal. 2016. PMID: 27156838
-
[The discovery of neuromedin U and its pivotal role in the central regulation of energy homeostasis].Postepy Hig Med Dosw (Online). 2012 Apr 16;66:196-203. doi: 10.5604/17322693.991448. Postepy Hig Med Dosw (Online). 2012. PMID: 22706104 Review. Polish.
-
Neuromedins NMU and NMS: An Updated Overview of Their Functions.Front Endocrinol (Lausanne). 2021 Jul 1;12:713961. doi: 10.3389/fendo.2021.713961. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34276571 Free PMC article. Review.
Cited by
-
Neuromedin B receptor stimulation of Cav3.2 T-type Ca2+ channels in primary sensory neurons mediates peripheral pain hypersensitivity.Theranostics. 2021 Sep 9;11(19):9342-9357. doi: 10.7150/thno.62255. eCollection 2021. Theranostics. 2021. PMID: 34646374 Free PMC article.
-
Effect of neuromedin U on allergic airway inflammation in an asthma model.Exp Ther Med. 2020 Feb;19(2):809-816. doi: 10.3892/etm.2019.8283. Epub 2019 Dec 4. Exp Ther Med. 2020. PMID: 32010240 Free PMC article. Review.
-
Cholecystokinin type B receptor-mediated inhibition of A-type K+ channels enhances sensory neuronal excitability through the phosphatidylinositol 3-kinase and c-Src-dependent JNK pathway.Cell Commun Signal. 2019 Jun 18;17(1):68. doi: 10.1186/s12964-019-0385-8. Cell Commun Signal. 2019. PMID: 31215470 Free PMC article.
-
Oncogenic features of neuromedin U in breast cancer are associated with NMUR2 expression involving crosstalk with members of the WNT signaling pathway.Oncotarget. 2017 May 30;8(22):36246-36265. doi: 10.18632/oncotarget.16121. Oncotarget. 2017. PMID: 28423716 Free PMC article.
-
The neuronal potassium current IA is a potential target for pain during chronic inflammation.Physiol Rep. 2021 Aug;9(16):e14975. doi: 10.14814/phy2.14975. Physiol Rep. 2021. PMID: 34405579 Free PMC article.
References
-
- Brighton P. J., Szekeres P. G., Willars G. B. (2004) Neuromedin U and its receptors. Structure, function, and physiological roles. Pharmacol. Rev. 56, 231–248 - PubMed
-
- Budhiraja S., Chugh A. (2009) Neuromedin U, physiology, pharmacology, and therapeutic potential. Fundam. Clin. Pharmacol. 23, 149–157 - PubMed
-
- Raddatz R., Wilson A. E., Artymyshyn R., Bonini J. A., Borowsky B., Boteju L. W., Zhou S., Kouranova E. V., Nagorny R., Guevarra M. S., Dai M., Lerman G. S., Vaysse P. J., Branchek T. A., Gerald C., Forray C., Adham N. (2000) Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system. J. Biol. Chem. 275, 32452–32459 - PubMed
-
- Shan L., Qiao X., Crona J. H., Behan J., Wang S., Laz T., Bayne M., Gustafson E. L., Monsma F. J., Jr., Hedrick J. A. (2000) Identification of a novel neuromedin U receptor subtype expressed in the central nervous system. J. Biol. Chem. 275, 39482–39486 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous